Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Itraconazole. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 19/20 | 0.77 |
| ▸ | ABCG2 | Q9UNQ0 | 4/20 | 0.77 |
| ▸ | LMNA | P02545 | 3/20 | 0.77 |
| ▸ | CYP51A1 | Q16850 | 3/20 | 0.77 |
| ▸ | ABCB11 | O95342 | 3/20 | 0.77 |
| ▸ | CYP8B1 | Q9UNU6 | 3/20 | 0.77 |
| ▸ | MAPT | P10636 | 3/20 | 0.77 |
| ▸ | MAPK1 | P28482 | 3/20 | 0.77 |
| ▸ | FYN | P06241 | 2/20 | 0.77 |
| ▸ | MEN1 | O00255 | 2/20 | 0.77 |
| ▸ | ABCB1 | P08183 | 2/20 | 0.77 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.77 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.77 |
| ▸ | CXCR1 | P25024 | 1/20 | 0.77 |
| ▸ | TACR1 | P25103 | 1/20 | 0.77 |
| ▸ | AVPR2 | P30518 | 1/20 | 0.77 |
| ▸ | CCR4 | P51679 | 1/20 | 0.77 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.77 |
| ▸ | NR1I2 | O75469 | 2/20 | 0.66 |
| ▸ | HSP90AA1 | P07900 | 2/20 | 0.66 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Itraconazole SCHEMBL1058775 | 0.97 | CYP3A4 (0.80) | CYP3A4ABCG2LMNACYP51A1ABCB11 | |
| Itraconazole SCHEMBL3675418 | 0.91 | CYP3A4 (0.70) | CYP3A4ABCG2LMNACYP51A1ABCB11 | |
| Itraconazole SCHEMBL8849763 | 0.90 | CYP3A4 (0.90) | CYP3A4ABCG2LMNACYP51A1ABCB11 | |
| Itraconazole SCHEMBL6152238 | 0.90 | CYP3A4 (0.94) | CYP3A4ABCG2LMNACYP51A1ABCB11 | |
| Posaconazole SCHEMBL20703831 | 0.90 | CYP3A4 (0.70) | CYP3A4ABCG2LMNACYP51A1ABCB11 | |
| Itraconazole SCHEMBL503873 | 0.89 | CYP3A4 (0.74) | CYP3A4ABCG2LMNACYP51A1ABCB11 | |
| Itraconazole SCHEMBL27699132 | 0.88 | CYP3A4 (0.97) | CYP3A4ABCG2LMNACYP51A1ABCB11 | |
| SCHEMBL2615052 | 0.88 | CYP3A4 (0.88) | CYP3A4ABCG2LMNACYP51A1ABCB11 | |
| Itraconazole SCHEMBL20464865 | 0.87 | CYP3A4 (1.00) | CYP3A4ABCG2LMNACYP51A1ABCB11 | |
| Itraconazole SCHEMBL15948108 | 0.87 | CYP3A4 (1.00) | CYP3A4ABCG2LMNACYP51A1ABCB11 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1667632-A4 | TREATMENT OF SEVERE DISTAL COLITIS | CHILDRENS MEDICAL CENTER (US) | 2009-07-01 | — | — | EP | disclosed |
| EP-1667632-A2 | TREATMENT OF SEVERE DISTAL COLITIS | Children's Medical Center Corporation (US) | 2006-06-14 | — | — | EP | disclosed |
| WO-2005027851-A2 | TREATMENT OF SEVERE DISTAL COLITIS | CHILDREN'S MEDICAL CENTER CORPORATION (US) | 2005-03-31 | — | — | WO | disclosed |